Catalyst
Slingshot members are tracking this event:
FDA Expands Indication of INVOKAMET (canagliflozin/metformin HCl) to Include First-Line Treatment of Adults with Type 2 Diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| Janssen | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 24, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Invokamet, Canagliflozin, Metformin Hcl, Type 2 Diabetes
